Near vision blurriness begins at age 40. Presbyopia or near vision blurriness is a natural part of aging where individuals experience difficulty reading printed words up close, checking websites onscreen or seeing objects at a distance.
Presbyopia can be corrected with progressive lenses that provide seamless vision between near, intermediate and far distances. Progressive lenses no longer have the distinct line found across traditional bi-focals, giving the wearer a more modern, youthful look.
Essilor, the inventor of progressive lenses, presents the Varilux® X seriesTM, designed to reinvent near vision by extending it further within arm’s reach.
“With the launch of the Varilux® X seriesTM, 40-year-olds and above no longer have to worry about vision problems. They can enjoy life with clear and healthy eye sight,” said Essilor Philippines general manager Dr. Emelita Roleda.
The most advanced progressive lens, the Varilux® X seriesTM uses a revolutionary technology called Xtend™. The result is near vision sharpness and fluidity within arm’s reach.
With today’s digital-focused life, 40-something individuals can comfortably and seamlessly capture every detail when viewing their smartphones, tablets and laptops.
See life clearly with the Varilux® X seriesTM progressive lenses.
Learn more about Varilux progressive lenses by visiting your eye care professional or leading optical shop by logging on to
The world's leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its mission is to improve lives by improving sight. To support this mission, Essilor allocates more than €200 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Its flagship brands are Varilux®, Crizal®, Crizal Transitions®, Crizal Eyezen™, Xperio®, It also develops and markets equipment, instruments and services for eye care professionals.
Essilor reported consolidated revenue of more than €7.1 billion in 2016 and employs 64,000 people worldwide. It markets its products in more than 100 countries and has 32 plants, 523 prescription laboratories and edging facilities, as well as five research and development centres around the world. For more information, please visit www.essilor.com.
The Essilor share trades on the Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices.